Puma Biotechnology
PBYI
PBYI
125 hedge funds and large institutions have $309M invested in Puma Biotechnology in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 43 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
6% less funds holding
Funds holding: 133 → 125 (-8)
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
Holders
125
Holding in Top 10
–
Calls
$3.45M
Puts
$3.81M
Top Buyers
| 1 | +$21.4M | |
| 2 | +$16.5M | |
| 3 | +$8.37M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.47M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$5.38M |
Top Sellers
| 1 | -$6.76M | |
| 2 | -$3.6M | |
| 3 | -$2.52M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.16M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.03M |